|drug921||Quercetin Prophylaxis Wiki||1.00|
|D011024||Pneumonia, Viral NIH||0.14|
|D045169||Severe Acute Respiratory Syndrome NIH||0.06|
|D018352||Coronavirus Infections NIH||0.05|
There is one clinical trial.
Novel Coronavirus is defined to be the cause of COVID-19, recently. It's known that COVID-19 goes with excessive immune reaction of human body in severe cases. The investigators hypothesize that quercetin, as a strong scavenger and anti-inflammatory agent, can be effective on both prophylaxis and treatment of COVID-19 cases. Therefore, the aim of this study to evaluate the possible role of quercetin on prophylaxis and treatment of COVID-19.
Description: Prevalence of COVID-19 in prophylaxis and sham group will be calculated using a questionnaire including hospital recordsMeasure: Prevalence of COVID-19 calculated using a questionnaire Time: 3 months
Description: Mortality rate will be compared between two groupsMeasure: Standardized Mortality rate Time: 3 months
Description: Morbidity rates besides recovery rates from COVID-19 will be documentedMeasure: Morbidity rate Time: 3 months